All Companies
BMYCongressional Stock Trades
Bristol-Myers Squibb Co.
Pharmaceutical Preparations
Congressional stock trades in Bristol-Myers Squibb Co. (BMY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
17
Politicians Trading
10
Last Traded
Jun 16, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Buy | $1,001 - $15,000 | +10.63% |
| Gilbert Ray Cisneros, Jr.D | Jan 12, 2026 | Dec 19, 2025 | Buy | $1,001 - $15,000 | +16.37% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 12, 2025 | Buy | $1,001 - $15,000 | +28.48% |
| Julie JohnsonD | Feb 12, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +12.79% |
Price History
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.